DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Burki TK.
NICE approves osimertinib for advanced lung cancer.
Lancet Respir Med 2016;
DOI: 10.1016/S2213-2600(16)30368-X.
We do not assume any responsibility for the contents of the web pages of other providers.